nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—DRD5—eyelid—head and neck cancer	0.051	0.176	CbGeAlD
Bromocriptine—Gastrointestinal ulcer—Hydroxyurea—head and neck cancer	0.0436	0.0842	CcSEcCtD
Bromocriptine—HTR7—superior cervical ganglion—head and neck cancer	0.0315	0.109	CbGeAlD
Bromocriptine—Fibrosis—Hydroxyurea—head and neck cancer	0.0236	0.0456	CcSEcCtD
Bromocriptine—HTR1B—trigeminal nerve—head and neck cancer	0.0231	0.0795	CbGeAlD
Bromocriptine—HTR1D—trigeminal nerve—head and neck cancer	0.0223	0.077	CbGeAlD
Bromocriptine—Fibrosis—Fluorouracil—head and neck cancer	0.017	0.0328	CcSEcCtD
Bromocriptine—HTR1B—cranial nerve—head and neck cancer	0.0164	0.0566	CbGeAlD
Bromocriptine—HTR1D—cranial nerve—head and neck cancer	0.0159	0.0548	CbGeAlD
Bromocriptine—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.0153	0.0296	CcSEcCtD
Bromocriptine—Lung infiltration—Hydroxyurea—head and neck cancer	0.0144	0.0278	CcSEcCtD
Bromocriptine—HTR7—cranial nerve—head and neck cancer	0.0127	0.0437	CbGeAlD
Bromocriptine—Pericarditis—Fluorouracil—head and neck cancer	0.0112	0.0217	CcSEcCtD
Bromocriptine—HTR2A—trigeminal nerve—head and neck cancer	0.0111	0.0382	CbGeAlD
Bromocriptine—Peptic ulcer—Vinblastine—head and neck cancer	0.0111	0.0214	CcSEcCtD
Bromocriptine—Parkinsonism—Fluorouracil—head and neck cancer	0.0107	0.0206	CcSEcCtD
Bromocriptine—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.00981	0.0189	CcSEcCtD
Bromocriptine—Neurotoxicity—Docetaxel—head and neck cancer	0.00904	0.0175	CcSEcCtD
Bromocriptine—Numbness—Vinblastine—head and neck cancer	0.00892	0.0172	CcSEcCtD
Bromocriptine—Pericardial effusion—Docetaxel—head and neck cancer	0.00854	0.0165	CcSEcCtD
Bromocriptine—Sensory loss—Vinblastine—head and neck cancer	0.00854	0.0165	CcSEcCtD
Bromocriptine—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.00797	0.0154	CcSEcCtD
Bromocriptine—HTR2A—cranial nerve—head and neck cancer	0.0079	0.0272	CbGeAlD
Bromocriptine—Tingling sensation—Fluorouracil—head and neck cancer	0.00604	0.0117	CcSEcCtD
Bromocriptine—Numbness—Fluorouracil—head and neck cancer	0.00586	0.0113	CcSEcCtD
Bromocriptine—Sensory loss—Fluorouracil—head and neck cancer	0.0056	0.0108	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00548	0.0106	CcSEcCtD
Bromocriptine—Burning sensation—Docetaxel—head and neck cancer	0.00504	0.00974	CcSEcCtD
Bromocriptine—Dermatitis atopic—Docetaxel—head and neck cancer	0.00473	0.00914	CcSEcCtD
Bromocriptine—Pleural effusion—Docetaxel—head and neck cancer	0.00458	0.00884	CcSEcCtD
Bromocriptine—Rhinorrhoea—Docetaxel—head and neck cancer	0.00433	0.00835	CcSEcCtD
Bromocriptine—HTR7—mouth—head and neck cancer	0.00427	0.0147	CbGeAlD
Bromocriptine—ADRA1D—epithelium—head and neck cancer	0.00417	0.0144	CbGeAlD
Bromocriptine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00408	0.00788	CcSEcCtD
Bromocriptine—Myocardial infarction—Vinblastine—head and neck cancer	0.00406	0.00783	CcSEcCtD
Bromocriptine—DRD5—lymphoid tissue—head and neck cancer	0.004	0.0138	CbGeAlD
Bromocriptine—Drowsiness—Hydroxyurea—head and neck cancer	0.00377	0.00729	CcSEcCtD
Bromocriptine—Hypoaesthesia—Vinblastine—head and neck cancer	0.0037	0.00714	CcSEcCtD
Bromocriptine—HTR7—neck—head and neck cancer	0.00365	0.0126	CbGeAlD
Bromocriptine—Lethargy—Fluorouracil—head and neck cancer	0.0036	0.00694	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00352	0.00681	CcSEcCtD
Bromocriptine—DRD3—head—head and neck cancer	0.00344	0.0119	CbGeAlD
Bromocriptine—Hallucination—Hydroxyurea—head and neck cancer	0.00337	0.00651	CcSEcCtD
Bromocriptine—Ataxia—Fluorouracil—head and neck cancer	0.00331	0.0064	CcSEcCtD
Bromocriptine—HTR6—head—head and neck cancer	0.00331	0.0114	CbGeAlD
Bromocriptine—Alopecia—Vinblastine—head and neck cancer	0.00328	0.00634	CcSEcCtD
Bromocriptine—HTR1D—connective tissue—head and neck cancer	0.00328	0.0113	CbGeAlD
Bromocriptine—DRD5—head—head and neck cancer	0.00323	0.0111	CbGeAlD
Bromocriptine—ADRB1—connective tissue—head and neck cancer	0.00319	0.011	CbGeAlD
Bromocriptine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00315	0.00609	CcSEcCtD
Bromocriptine—Lightheadedness—Docetaxel—head and neck cancer	0.00314	0.00605	CcSEcCtD
Bromocriptine—Angiopathy—Hydroxyurea—head and neck cancer	0.00307	0.00593	CcSEcCtD
Bromocriptine—Dysphagia—Fluorouracil—head and neck cancer	0.00305	0.00588	CcSEcCtD
Bromocriptine—Alopecia—Hydroxyurea—head and neck cancer	0.00299	0.00578	CcSEcCtD
Bromocriptine—Vertigo—Vinblastine—head and neck cancer	0.0029	0.00561	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.0028	0.00542	CcSEcCtD
Bromocriptine—Convulsion—Vinblastine—head and neck cancer	0.0028	0.00541	CcSEcCtD
Bromocriptine—Hypertension—Vinblastine—head and neck cancer	0.00279	0.00539	CcSEcCtD
Bromocriptine—ADRA2C—parotid gland—head and neck cancer	0.00273	0.00941	CbGeAlD
Bromocriptine—Visual disturbance—Docetaxel—head and neck cancer	0.00268	0.00518	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00268	0.00517	CcSEcCtD
Bromocriptine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00266	0.00514	CcSEcCtD
Bromocriptine—ADRA1B—head—head and neck cancer	0.00264	0.00912	CbGeAlD
Bromocriptine—HTR7—connective tissue—head and neck cancer	0.00261	0.00901	CbGeAlD
Bromocriptine—Lethargy—Docetaxel—head and neck cancer	0.0026	0.00501	CcSEcCtD
Bromocriptine—ADRA1D—head—head and neck cancer	0.00259	0.00892	CbGeAlD
Bromocriptine—Convulsion—Hydroxyurea—head and neck cancer	0.00255	0.00493	CcSEcCtD
Bromocriptine—Sinusitis—Fluorouracil—head and neck cancer	0.00255	0.00492	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00254	0.00491	CcSEcCtD
Bromocriptine—Anorexia—Vinblastine—head and neck cancer	0.00252	0.00486	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00249	0.00481	CcSEcCtD
Bromocriptine—HTR7—epithelium—head and neck cancer	0.00248	0.00856	CbGeAlD
Bromocriptine—DRD1—head—head and neck cancer	0.00246	0.0085	CbGeAlD
Bromocriptine—Rhinitis—Fluorouracil—head and neck cancer	0.00244	0.00472	CcSEcCtD
Bromocriptine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00243	0.00468	CcSEcCtD
Bromocriptine—Oedema—Hydroxyurea—head and neck cancer	0.00241	0.00465	CcSEcCtD
Bromocriptine—ADRA1A—epithelium—head and neck cancer	0.00239	0.00825	CbGeAlD
Bromocriptine—Ataxia—Docetaxel—head and neck cancer	0.00239	0.00462	CcSEcCtD
Bromocriptine—Infection—Hydroxyurea—head and neck cancer	0.00239	0.00462	CcSEcCtD
Bromocriptine—Paraesthesia—Vinblastine—head and neck cancer	0.00237	0.00458	CcSEcCtD
Bromocriptine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00236	0.00456	CcSEcCtD
Bromocriptine—Skin disorder—Hydroxyurea—head and neck cancer	0.00234	0.00451	CcSEcCtD
Bromocriptine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00232	0.00449	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00232	0.00449	CcSEcCtD
Bromocriptine—Anorexia—Hydroxyurea—head and neck cancer	0.00229	0.00443	CcSEcCtD
Bromocriptine—Decreased appetite—Vinblastine—head and neck cancer	0.00229	0.00443	CcSEcCtD
Bromocriptine—Cramp muscle—Docetaxel—head and neck cancer	0.00229	0.00442	CcSEcCtD
Bromocriptine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00227	0.00439	CcSEcCtD
Bromocriptine—HTR2A—neck—head and neck cancer	0.00227	0.00784	CbGeAlD
Bromocriptine—Constipation—Vinblastine—head and neck cancer	0.00226	0.00436	CcSEcCtD
Bromocriptine—Dysphagia—Docetaxel—head and neck cancer	0.0022	0.00425	CcSEcCtD
Bromocriptine—HTR7—trachea—head and neck cancer	0.00219	0.00757	CbGeAlD
Bromocriptine—Arrhythmia—Fluorouracil—head and neck cancer	0.00218	0.00421	CcSEcCtD
Bromocriptine—Feeling abnormal—Vinblastine—head and neck cancer	0.00217	0.0042	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00216	0.00417	CcSEcCtD
Bromocriptine—Alopecia—Fluorouracil—head and neck cancer	0.00215	0.00416	CcSEcCtD
Bromocriptine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00215	0.00414	CcSEcCtD
Bromocriptine—Somnolence—Hydroxyurea—head and neck cancer	0.00214	0.00413	CcSEcCtD
Bromocriptine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00212	0.00409	CcSEcCtD
Bromocriptine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00209	0.00404	CcSEcCtD
Bromocriptine—Abdominal pain—Vinblastine—head and neck cancer	0.00209	0.00403	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00208	0.00401	CcSEcCtD
Bromocriptine—Fatigue—Hydroxyurea—head and neck cancer	0.00207	0.00401	CcSEcCtD
Bromocriptine—Constipation—Hydroxyurea—head and neck cancer	0.00206	0.00397	CcSEcCtD
Bromocriptine—HTR2B—thyroid gland—head and neck cancer	0.00203	0.00699	CbGeAlD
Bromocriptine—ADRA2C—trachea—head and neck cancer	0.00202	0.00695	CbGeAlD
Bromocriptine—Vision blurred—Fluorouracil—head and neck cancer	0.002	0.00386	CcSEcCtD
Bromocriptine—HTR1B—head—head and neck cancer	0.002	0.00689	CbGeAlD
Bromocriptine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00198	0.00383	CcSEcCtD
Bromocriptine—HTR1D—head—head and neck cancer	0.00193	0.00667	CbGeAlD
Bromocriptine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00193	0.00373	CcSEcCtD
Bromocriptine—Myocardial infarction—Docetaxel—head and neck cancer	0.00192	0.00371	CcSEcCtD
Bromocriptine—ADRA2A—connective tissue—head and neck cancer	0.00192	0.00661	CbGeAlD
Bromocriptine—HTR2C—head—head and neck cancer	0.00191	0.0066	CbGeAlD
Bromocriptine—Body temperature increased—Hydroxyurea—head and neck cancer	0.0019	0.00367	CcSEcCtD
Bromocriptine—Asthenia—Vinblastine—head and neck cancer	0.00189	0.00366	CcSEcCtD
Bromocriptine—ADRB1—head—head and neck cancer	0.00188	0.00648	CbGeAlD
Bromocriptine—ADRA1A—lymphoid tissue—head and neck cancer	0.00184	0.00636	CbGeAlD
Bromocriptine—Convulsion—Fluorouracil—head and neck cancer	0.00184	0.00355	CcSEcCtD
Bromocriptine—Diarrhoea—Vinblastine—head and neck cancer	0.00181	0.00349	CcSEcCtD
Bromocriptine—HTR2B—head—head and neck cancer	0.0018	0.0062	CbGeAlD
Bromocriptine—Rhinitis—Docetaxel—head and neck cancer	0.00176	0.00341	CcSEcCtD
Bromocriptine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00175	0.00338	CcSEcCtD
Bromocriptine—Confusional state—Fluorouracil—head and neck cancer	0.00175	0.00337	CcSEcCtD
Bromocriptine—Dizziness—Vinblastine—head and neck cancer	0.00174	0.00337	CcSEcCtD
Bromocriptine—Oedema peripheral—Docetaxel—head and neck cancer	0.00173	0.00335	CcSEcCtD
Bromocriptine—Oedema—Fluorouracil—head and neck cancer	0.00173	0.00334	CcSEcCtD
Bromocriptine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00173	0.00334	CcSEcCtD
Bromocriptine—Asthenia—Hydroxyurea—head and neck cancer	0.00173	0.00333	CcSEcCtD
Bromocriptine—Infection—Fluorouracil—head and neck cancer	0.00172	0.00332	CcSEcCtD
Bromocriptine—Nervous system disorder—Fluorouracil—head and neck cancer	0.0017	0.00328	CcSEcCtD
Bromocriptine—Visual impairment—Docetaxel—head and neck cancer	0.0017	0.00327	CcSEcCtD
Bromocriptine—Tachycardia—Fluorouracil—head and neck cancer	0.00169	0.00326	CcSEcCtD
Bromocriptine—Vomiting—Vinblastine—head and neck cancer	0.00168	0.00324	CcSEcCtD
Bromocriptine—Headache—Vinblastine—head and neck cancer	0.00165	0.00319	CcSEcCtD
Bromocriptine—Anorexia—Fluorouracil—head and neck cancer	0.00165	0.00319	CcSEcCtD
Bromocriptine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00165	0.00318	CcSEcCtD
Bromocriptine—Eye disorder—Docetaxel—head and neck cancer	0.00164	0.00318	CcSEcCtD
Bromocriptine—Cardiac disorder—Docetaxel—head and neck cancer	0.00163	0.00315	CcSEcCtD
Bromocriptine—HTR2A—connective tissue—head and neck cancer	0.00163	0.00562	CbGeAlD
Bromocriptine—Hypotension—Fluorouracil—head and neck cancer	0.00162	0.00313	CcSEcCtD
Bromocriptine—HTR1A—head—head and neck cancer	0.00161	0.00556	CbGeAlD
Bromocriptine—ADRA2A—trachea—head and neck cancer	0.00161	0.00555	CbGeAlD
Bromocriptine—Angiopathy—Docetaxel—head and neck cancer	0.0016	0.00308	CcSEcCtD
Bromocriptine—Dizziness—Hydroxyurea—head and neck cancer	0.00159	0.00307	CcSEcCtD
Bromocriptine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00159	0.00306	CcSEcCtD
Bromocriptine—Arrhythmia—Docetaxel—head and neck cancer	0.00157	0.00304	CcSEcCtD
Bromocriptine—Nausea—Vinblastine—head and neck cancer	0.00157	0.00303	CcSEcCtD
Bromocriptine—Insomnia—Fluorouracil—head and neck cancer	0.00157	0.00303	CcSEcCtD
Bromocriptine—Paraesthesia—Fluorouracil—head and neck cancer	0.00156	0.003	CcSEcCtD
Bromocriptine—Alopecia—Docetaxel—head and neck cancer	0.00156	0.003	CcSEcCtD
Bromocriptine—HTR2A—epithelium—head and neck cancer	0.00155	0.00534	CbGeAlD
Bromocriptine—Dyspnoea—Fluorouracil—head and neck cancer	0.00154	0.00298	CcSEcCtD
Bromocriptine—Mental disorder—Docetaxel—head and neck cancer	0.00154	0.00298	CcSEcCtD
Bromocriptine—HTR7—head—head and neck cancer	0.00154	0.00531	CbGeAlD
Bromocriptine—Somnolence—Fluorouracil—head and neck cancer	0.00154	0.00297	CcSEcCtD
Bromocriptine—Vomiting—Hydroxyurea—head and neck cancer	0.00153	0.00295	CcSEcCtD
Bromocriptine—Dyspepsia—Fluorouracil—head and neck cancer	0.00152	0.00294	CcSEcCtD
Bromocriptine—Rash—Hydroxyurea—head and neck cancer	0.00152	0.00293	CcSEcCtD
Bromocriptine—Dermatitis—Hydroxyurea—head and neck cancer	0.00152	0.00293	CcSEcCtD
Bromocriptine—Headache—Hydroxyurea—head and neck cancer	0.00151	0.00291	CcSEcCtD
Bromocriptine—Decreased appetite—Fluorouracil—head and neck cancer	0.00151	0.00291	CcSEcCtD
Bromocriptine—Dysgeusia—Docetaxel—head and neck cancer	0.0015	0.0029	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0015	0.00289	CcSEcCtD
Bromocriptine—ADRA1A—head—head and neck cancer	0.00149	0.00512	CbGeAlD
Bromocriptine—Muscle spasms—Docetaxel—head and neck cancer	0.00147	0.00284	CcSEcCtD
Bromocriptine—DRD2—head—head and neck cancer	0.00146	0.00502	CbGeAlD
Bromocriptine—Nausea—Hydroxyurea—head and neck cancer	0.00143	0.00276	CcSEcCtD
Bromocriptine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00143	0.00276	CcSEcCtD
Bromocriptine—ADRA2C—head—head and neck cancer	0.00142	0.00488	CbGeAlD
Bromocriptine—CYP1A2—thyroid gland—head and neck cancer	0.00138	0.00477	CbGeAlD
Bromocriptine—Urticaria—Fluorouracil—head and neck cancer	0.00138	0.00266	CcSEcCtD
Bromocriptine—Syncope—Docetaxel—head and neck cancer	0.00137	0.00265	CcSEcCtD
Bromocriptine—Body temperature increased—Fluorouracil—head and neck cancer	0.00137	0.00264	CcSEcCtD
Bromocriptine—HTR2A—trachea—head and neck cancer	0.00137	0.00472	CbGeAlD
Bromocriptine—Loss of consciousness—Docetaxel—head and neck cancer	0.00135	0.0026	CcSEcCtD
Bromocriptine—Convulsion—Docetaxel—head and neck cancer	0.00133	0.00256	CcSEcCtD
Bromocriptine—Hypertension—Docetaxel—head and neck cancer	0.00132	0.00255	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.0013	0.0025	CcSEcCtD
Bromocriptine—Dry mouth—Docetaxel—head and neck cancer	0.00128	0.00246	CcSEcCtD
Bromocriptine—ADRA2A—thyroid gland—head and neck cancer	0.00127	0.00439	CbGeAlD
Bromocriptine—Confusional state—Docetaxel—head and neck cancer	0.00126	0.00243	CcSEcCtD
Bromocriptine—HTR2B—lymph node—head and neck cancer	0.00126	0.00434	CbGeAlD
Bromocriptine—Oedema—Docetaxel—head and neck cancer	0.00125	0.00241	CcSEcCtD
Bromocriptine—Infection—Docetaxel—head and neck cancer	0.00124	0.0024	CcSEcCtD
Bromocriptine—Shock—Docetaxel—head and neck cancer	0.00123	0.00238	CcSEcCtD
Bromocriptine—Nervous system disorder—Docetaxel—head and neck cancer	0.00123	0.00237	CcSEcCtD
Bromocriptine—Tachycardia—Docetaxel—head and neck cancer	0.00122	0.00236	CcSEcCtD
Bromocriptine—Skin disorder—Docetaxel—head and neck cancer	0.00121	0.00234	CcSEcCtD
Bromocriptine—Anorexia—Docetaxel—head and neck cancer	0.00119	0.0023	CcSEcCtD
Bromocriptine—Diarrhoea—Fluorouracil—head and neck cancer	0.00119	0.00229	CcSEcCtD
Bromocriptine—Hypotension—Docetaxel—head and neck cancer	0.00117	0.00226	CcSEcCtD
Bromocriptine—Dizziness—Fluorouracil—head and neck cancer	0.00115	0.00221	CcSEcCtD
Bromocriptine—Insomnia—Docetaxel—head and neck cancer	0.00113	0.00218	CcSEcCtD
Bromocriptine—ADRA2A—head—head and neck cancer	0.00113	0.00389	CbGeAlD
Bromocriptine—Paraesthesia—Docetaxel—head and neck cancer	0.00112	0.00217	CcSEcCtD
Bromocriptine—Dyspnoea—Docetaxel—head and neck cancer	0.00111	0.00215	CcSEcCtD
Bromocriptine—Somnolence—Docetaxel—head and neck cancer	0.00111	0.00215	CcSEcCtD
Bromocriptine—Vomiting—Fluorouracil—head and neck cancer	0.0011	0.00213	CcSEcCtD
Bromocriptine—Dyspepsia—Docetaxel—head and neck cancer	0.0011	0.00213	CcSEcCtD
Bromocriptine—Rash—Fluorouracil—head and neck cancer	0.00109	0.00211	CcSEcCtD
Bromocriptine—Dermatitis—Fluorouracil—head and neck cancer	0.00109	0.00211	CcSEcCtD
Bromocriptine—Decreased appetite—Docetaxel—head and neck cancer	0.00109	0.0021	CcSEcCtD
Bromocriptine—Headache—Fluorouracil—head and neck cancer	0.00109	0.0021	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00108	0.00208	CcSEcCtD
Bromocriptine—Fatigue—Docetaxel—head and neck cancer	0.00108	0.00208	CcSEcCtD
Bromocriptine—Constipation—Docetaxel—head and neck cancer	0.00107	0.00206	CcSEcCtD
Bromocriptine—Feeling abnormal—Docetaxel—head and neck cancer	0.00103	0.00199	CcSEcCtD
Bromocriptine—Nausea—Fluorouracil—head and neck cancer	0.00103	0.00199	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00102	0.00197	CcSEcCtD
Bromocriptine—ABCB1—epithelium—head and neck cancer	0.00101	0.0035	CbGeAlD
Bromocriptine—ADRA2C—lymph node—head and neck cancer	0.000991	0.00342	CbGeAlD
Bromocriptine—Abdominal pain—Docetaxel—head and neck cancer	0.000988	0.00191	CcSEcCtD
Bromocriptine—Body temperature increased—Docetaxel—head and neck cancer	0.000988	0.00191	CcSEcCtD
Bromocriptine—HTR2A—head—head and neck cancer	0.00096	0.00331	CbGeAlD
Bromocriptine—Asthenia—Docetaxel—head and neck cancer	0.000897	0.00173	CcSEcCtD
Bromocriptine—ABCB1—trachea—head and neck cancer	0.000897	0.00309	CbGeAlD
Bromocriptine—Diarrhoea—Docetaxel—head and neck cancer	0.000855	0.00165	CcSEcCtD
Bromocriptine—Dizziness—Docetaxel—head and neck cancer	0.000827	0.0016	CcSEcCtD
Bromocriptine—Vomiting—Docetaxel—head and neck cancer	0.000795	0.00153	CcSEcCtD
Bromocriptine—ADRA2A—lymph node—head and neck cancer	0.000791	0.00273	CbGeAlD
Bromocriptine—Rash—Docetaxel—head and neck cancer	0.000788	0.00152	CcSEcCtD
Bromocriptine—Dermatitis—Docetaxel—head and neck cancer	0.000788	0.00152	CcSEcCtD
Bromocriptine—Headache—Docetaxel—head and neck cancer	0.000783	0.00151	CcSEcCtD
Bromocriptine—ABCB1—lymphoid tissue—head and neck cancer	0.000781	0.00269	CbGeAlD
Bromocriptine—Nausea—Docetaxel—head and neck cancer	0.000743	0.00143	CcSEcCtD
Bromocriptine—ABCB1—thyroid gland—head and neck cancer	0.000709	0.00245	CbGeAlD
Bromocriptine—ABCB1—head—head and neck cancer	0.000629	0.00217	CbGeAlD
Bromocriptine—ABCB1—lymph node—head and neck cancer	0.000441	0.00152	CbGeAlD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	3.08e-05	0.00016	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	3.08e-05	0.00016	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.07e-05	0.00016	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—head and neck cancer	3.07e-05	0.00016	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	3.05e-05	0.000159	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK3—head and neck cancer	3.05e-05	0.000159	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—STAT3—head and neck cancer	3.05e-05	0.000159	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—head and neck cancer	3.04e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	3.04e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MAPK1—head and neck cancer	3.03e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—head and neck cancer	3.03e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MAPK1—head and neck cancer	3.03e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—head and neck cancer	3.03e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	3.01e-05	0.000157	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—head and neck cancer	3.01e-05	0.000157	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCND1—head and neck cancer	2.99e-05	0.000156	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	2.99e-05	0.000156	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	2.99e-05	0.000156	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—head and neck cancer	2.98e-05	0.000155	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	2.97e-05	0.000155	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	2.97e-05	0.000154	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—HRAS—head and neck cancer	2.95e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	2.95e-05	0.000154	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—TYMS—head and neck cancer	2.95e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	2.95e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—head and neck cancer	2.95e-05	0.000153	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—head and neck cancer	2.94e-05	0.000153	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—head and neck cancer	2.92e-05	0.000152	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.92e-05	0.000152	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	2.91e-05	0.000152	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	2.91e-05	0.000151	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—head and neck cancer	2.9e-05	0.000151	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK1—head and neck cancer	2.9e-05	0.000151	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—head and neck cancer	2.9e-05	0.000151	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	2.9e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PTEN—head and neck cancer	2.89e-05	0.00015	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—head and neck cancer	2.87e-05	0.00015	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—head and neck cancer	2.87e-05	0.00015	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	2.86e-05	0.000149	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—head and neck cancer	2.86e-05	0.000149	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	2.86e-05	0.000149	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	2.86e-05	0.000149	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	2.86e-05	0.000149	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	2.85e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	2.85e-05	0.000148	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—head and neck cancer	2.84e-05	0.000148	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—head and neck cancer	2.84e-05	0.000148	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	2.84e-05	0.000148	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	2.83e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	2.82e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	2.8e-05	0.000146	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX1—head and neck cancer	2.79e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	2.79e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	2.79e-05	0.000145	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—head and neck cancer	2.79e-05	0.000145	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	2.77e-05	0.000144	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCND1—head and neck cancer	2.77e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—head and neck cancer	2.77e-05	0.000144	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.76e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	2.76e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	2.75e-05	0.000143	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK3—head and neck cancer	2.75e-05	0.000143	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	2.73e-05	0.000142	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	2.71e-05	0.000141	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK3—head and neck cancer	2.71e-05	0.000141	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	2.7e-05	0.00014	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	2.68e-05	0.00014	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	2.68e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	2.67e-05	0.000139	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	2.64e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	2.63e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	2.63e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	2.63e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	2.61e-05	0.000136	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK1—head and neck cancer	2.61e-05	0.000136	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—head and neck cancer	2.61e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	2.61e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	2.61e-05	0.000136	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	2.61e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTEN—head and neck cancer	2.6e-05	0.000135	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	2.59e-05	0.000135	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	2.59e-05	0.000135	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK1—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—head and neck cancer	2.58e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	2.57e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	2.56e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	2.56e-05	0.000133	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	2.56e-05	0.000133	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—head and neck cancer	2.55e-05	0.000133	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—head and neck cancer	2.54e-05	0.000132	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—head and neck cancer	2.54e-05	0.000132	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—head and neck cancer	2.53e-05	0.000132	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	2.52e-05	0.000131	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—head and neck cancer	2.51e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	2.51e-05	0.000131	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	2.5e-05	0.00013	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	2.48e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	2.48e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—head and neck cancer	2.48e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	2.47e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	2.47e-05	0.000129	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	2.47e-05	0.000128	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	2.46e-05	0.000128	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	2.45e-05	0.000127	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—head and neck cancer	2.44e-05	0.000127	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—head and neck cancer	2.44e-05	0.000127	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—head and neck cancer	2.43e-05	0.000127	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—head and neck cancer	2.43e-05	0.000126	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	2.42e-05	0.000126	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—head and neck cancer	2.42e-05	0.000126	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	2.42e-05	0.000126	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	2.4e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	2.4e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	2.39e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	2.39e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	2.38e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—head and neck cancer	2.37e-05	0.000123	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	2.37e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	2.36e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	2.35e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	2.35e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	2.35e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—head and neck cancer	2.35e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	2.34e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	2.33e-05	0.000121	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—head and neck cancer	2.33e-05	0.000121	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	2.33e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	2.33e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	2.33e-05	0.000121	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—head and neck cancer	2.33e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	2.31e-05	0.00012	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	2.28e-05	0.000119	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	2.28e-05	0.000119	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TYMS—head and neck cancer	2.28e-05	0.000119	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.27e-05	0.000118	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	2.27e-05	0.000118	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—head and neck cancer	2.26e-05	0.000117	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.25e-05	0.000117	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	2.25e-05	0.000117	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	2.25e-05	0.000117	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	2.25e-05	0.000117	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	2.25e-05	0.000117	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	2.24e-05	0.000116	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	2.24e-05	0.000116	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	2.23e-05	0.000116	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	2.23e-05	0.000116	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—head and neck cancer	2.22e-05	0.000116	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—head and neck cancer	2.19e-05	0.000114	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	2.19e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	2.17e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	2.17e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	2.17e-05	0.000113	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—head and neck cancer	2.17e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—head and neck cancer	2.16e-05	0.000113	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—head and neck cancer	2.16e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	2.16e-05	0.000112	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—head and neck cancer	2.16e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—head and neck cancer	2.15e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—head and neck cancer	2.15e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	2.14e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	2.14e-05	0.000111	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—head and neck cancer	2.13e-05	0.000111	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	2.13e-05	0.000111	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.13e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	2.12e-05	0.00011	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	2.11e-05	0.00011	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—head and neck cancer	2.1e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—head and neck cancer	2.09e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	2.09e-05	0.000109	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	2.07e-05	0.000108	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—head and neck cancer	2.07e-05	0.000108	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	2.07e-05	0.000108	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—head and neck cancer	2.06e-05	0.000107	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—head and neck cancer	2.06e-05	0.000107	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	2.04e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	2.04e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	2.02e-05	0.000105	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	2e-05	0.000104	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.97e-05	0.000103	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.97e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—head and neck cancer	1.97e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—head and neck cancer	1.96e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.96e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—head and neck cancer	1.95e-05	0.000102	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	1.95e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.94e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.94e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.94e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.94e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.9e-05	9.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.9e-05	9.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	1.89e-05	9.82e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—head and neck cancer	1.89e-05	9.82e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—head and neck cancer	1.89e-05	9.82e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.88e-05	9.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	1.87e-05	9.73e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.86e-05	9.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.86e-05	9.66e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—head and neck cancer	1.85e-05	9.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—head and neck cancer	1.84e-05	9.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.83e-05	9.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	1.83e-05	9.51e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—head and neck cancer	1.83e-05	9.51e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—head and neck cancer	1.82e-05	9.5e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	1.8e-05	9.39e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—head and neck cancer	1.8e-05	9.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	1.8e-05	9.35e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	1.79e-05	9.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	1.77e-05	9.19e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	1.77e-05	9.19e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	1.75e-05	9.08e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.72e-05	8.94e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.71e-05	8.91e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	1.68e-05	8.77e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—head and neck cancer	1.66e-05	8.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—head and neck cancer	1.66e-05	8.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	1.65e-05	8.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.65e-05	8.58e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.64e-05	8.56e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—head and neck cancer	1.63e-05	8.48e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.6e-05	8.3e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	1.59e-05	8.29e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	1.58e-05	8.25e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—head and neck cancer	1.58e-05	8.24e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	1.56e-05	8.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	1.54e-05	8.02e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	1.53e-05	7.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.53e-05	7.94e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.52e-05	7.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—head and neck cancer	1.5e-05	7.79e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	1.48e-05	7.72e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.43e-05	7.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	1.42e-05	7.38e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—head and neck cancer	1.4e-05	7.28e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	1.38e-05	7.16e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	1.35e-05	7.01e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.27e-05	6.61e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.27e-05	6.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	1.25e-05	6.52e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.11e-05	5.76e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—head and neck cancer	1.04e-05	5.39e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.01e-05	5.27e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—head and neck cancer	8.26e-06	4.3e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.81e-06	4.06e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—head and neck cancer	6.38e-06	3.32e-05	CbGpPWpGaD
